0001104659-21-000919.txt : 20210105 0001104659-21-000919.hdr.sgml : 20210105 20210105160902 ACCESSION NUMBER: 0001104659-21-000919 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210105 DATE AS OF CHANGE: 20210105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bakshi Akash CENTRAL INDEX KEY: 0001836243 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 21505491 MAIL ADDRESS: STREET 1: 602 BAINBRIDGE STREET CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BERKELEY ST. STREET 2: FL 19 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (857) 702-9600 MAIL ADDRESS: STREET 1: 200 BERKELEY ST. STREET 2: FL 19 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Gemphire Therapeutics Inc. DATE OF NAME CHANGE: 20150331 4 1 a4.xml 4 X0306 4 2020-12-31 0 0001638287 NeuroBo Pharmaceuticals, Inc. NRBO 0001836243 Bakshi Akash C/O NEUROBO PHARMACEUTICALS, INC., 200 BERKELEY STREET, OFFICE 19TH FLOOR BOSTON MA 02116 1 1 0 0 SVP and COO Common Stock 2020-12-31 4 A 0 29013 A 29013 D Common Stock 2020-12-31 4 A 0 855059 A 884072 I See Footnote Received in exchange for shares of ANA Therapeutics, Inc. ("ANA") common stock in connection with the acquisition of ANA by the Company. The reportable securities are owned directly by YourChoice Holdings, LLC ("YourChoice"). Mr. Bakshi is the CEO and a director of YourChoice. Mr. Bakshi disclaims beneficial ownership of the securities reported herein for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. /s/ Akash Bakshi 2021-01-05